Percent of Male Medicare Beneficiaries Age 75 and Older Having a Screening PSA Test
  • Print
  • PDF
  • Embed

    Copy the following code and paste it into your website in order to display the current report.

  • Download to Excel

Customize Report

    • YEAR:

    Choose Locations

    [clear all] [select all] Selected Locations:

      Choose Indicator(s)

      Select one or more indicators
      • TOPIC:
      • INDICATOR:
      • YEAR:

      [clear all] Selected Indicators:


    (Click a region name
    below to view its profile)
    Percent of Male Medicare Beneficiaries Age 75 and Older Having a Screening PSA Test
    (Year: 2014; Region Levels: State)
    Alabama 23.2%
    Florida 23.0%
    Georgia 21.9%
    New York 21.6%
    New Jersey 21.2%
    Tennessee 20.8%
    Michigan 20.8%
    Louisiana 20.5%
    Hawaii 19.9%
    South Carolina 19.9%
    Mississippi 19.8%
    Texas 19.0%
    California 18.9%
    Arizona 18.9%
    Oklahoma 18.6%
    Kansas 18.3%
    Arkansas 18.2%
    Kentucky 18.0%
    Illinois 18.0%
    North Carolina 17.7%
    Ohio 17.3%
    Delaware 17.2%
    West Virginia 17.2%
    Indiana 17.1%
    Pennsylvania 17.0%
    Missouri 16.8%
    Rhode Island 16.7%
    Connecticut 16.7%
    North Dakota 16.1%
    Nebraska 16.1%
    Maryland 15.9%
    South Dakota 15.8%
    Nevada 15.3%
    Virginia 15.3%
    Massachusetts 15.1%
    District of Columbia 15.0%
    Iowa 14.3%
    Idaho 14.2%
    Utah 14.1%
    Montana 14.0%
    New Mexico 13.3%
    Colorado 12.8%
    Washington 12.6%
    Alaska 12.6%
    Oregon 12.6%
    Wisconsin 12.1%
    New Hampshire 12.0%
    Wyoming 11.1%
    Minnesota 10.5%
    Vermont 9.7%
    Maine 9.6%
    National Average 18.2%
    90th Percentile 20.8%
    50th Percentile 16.8%
    10th Percentile 12.1%
        • FOOTNOTES:
        • PSA screening rates are not adjusted; because the measure is already restricted by age and sex, statistical adjustments to correct for underlying population differences are not relevant.

        • The denominator consisted of male Medicare enrollees age 75-99 on January 1, 2012 who were eligible for Medicare Parts A and B and not enrolled in risk-bearing HMOs at any time during the year. Excluded from the analysis were men who had a PSA test for a presumed screening indication, men who had any history of prostate disease (prostate cancer, prostate surgery, or diagnosis of elevated PSA in the prior three years), and men who had prostate cancer-like symptoms in the three months before a PSA test based on diagnostic codes billed on visits and hospitalizations.

        • PSA screening was defined as any, but only one occurrence per patient during 2012 of CPT codes G0103 and 84153.


    © 2018 The Trustees of Dartmouth College | 35 Centerra Parkway, Lebanon, NH 03766 | (603) 653-0800

    The Dartmouth Atlas of Health Care is based at The Dartmouth Institute for Health Policy and Clinical Practice and is supported by a coalition of funders led by the Robert Wood Johnson Foundation, including the WellPoint Foundation, the United Health Foundation, the California HealthCare Foundation, and the Charles H. Hood Foundation.